Revive Files IND Application With FDA For Phase 3 Clinical Study For COVID-19 Treatment
Revive Therapeutics (CSE: RVV) announced after the bell today that it has officially filed its investigational new drug (IND) application
Read more
Clinical Trials
Revive Files Clinical Trial Application With Health Canada, Releases Phase 3 FDA Study Design For Potential Treatment Of COVID-19
Revive Therapeutics (CSE: RVV) continues to advance its clinical trial efforts. The company announced this morning that it has filed
Read more
Shroom Progress! MindMed Advances Towards a Phase 2 LSD Microdosing Trial For Adult ADHD
Aftermarket MindMed (NEO:MMED) announced they entered into a clinical trial agreement with Maastricht University to undertake a Phase 2a clinical trial for
Read more